profit from every €100 of sales.
€0€100
DSM-Firmenich
€105.15-0.90% today
+51.8% since Dec 22, 25
1-year low €55.421-year high €113.30
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What DSM-Firmenich sold, what it kept, and what it did with the cash.
Sales went from €8.39 billion in 2022 to €9.03 billion in 2025, with -€1.08 billion of profit last year.
SalesProfit
DSM-Firmenich handed back more cash to shareholders than it generated last year.
Buybacks €1.2B€718M
Free cash flow 2025€651M
Bought back its own shares€1.2B
Paid as dividends€718M
Cash vs. debt€1.8B vs. €5.3B
DSM-Firmenich vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| DSM-Firmenich | No profit yet | ||
 Linde | 34.8× · Expensive | ||
 L'Air Liquide | 35.0× · Expensive | ||
 Ecolab | 41.1× · Expensive | ||
 The Sherwin-Williams | 33.1× · Expensive |
AI analysis
An AI analyst reads DSM-Firmenich's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 8,390 | 10,627 | 9,054 | 9,034 | |
| 2,690 | 2,611 | 3,553 | 3,530 | |
| 657 | -507 | 551 | 632 | |
| 1,376 | 501 | 1,774 | 3,849 | |
| 1,700 | 2,137 | 250 | -1,081 | |
| 11.24 | 9.13 | 0.84 | – | |
| 32.1% | 24.6% | 39.2% | 39.1% | |
| 7.8% | -4.8% | 6.1% | 7.0% | |
| 20.3% | 20.1% | 2.8% | -12.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17,403 | 34,270 | 33,747 | 29,345 |
| Cash | 2,755 | 2,456 | 2,667 | 1,782 |
| Total debt | 3,064 | 4,830 | 5,280 | 5,277 |
| Total liabilities | 6,558 | 11,200 | 11,050 | 10,922 |
| 10,743 | 22,908 | 22,511 | 18,244 | |
| 151 | 233 | 265 | – | |
| 3.9% | -1.3% | 1.6% | 2.3% | |
| 15.8% | 9.3% | 1.1% | -5.9% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 965 | 1,265 | 1,778 | 1,445 | |
| 684 | 707 | 772 | 794 | |
| 281 | 558 | 1,006 | 651 | |
| Dividends paid | 345 | 582 | 667 | 718 |
| 210 | 256 | 706 | 1,181 | |
| 34 | 23 | 31 | 38 |
Valuation
- –
- –
- –
- 1.0×
- 2.8×
- 39.5×
- 7.6×
- 2.5%
- -4.2%
- 2.8%
Profitability
- 39.1%
- 7.0%
- -12.0%
- –
- 2.3%
- 1.6%
- –
- –
- –
- –
Growth
- +2.5%
- –
- –
- –
- +20.6%
Financial health
- 0.9×
- 0.29
- –
- 4.6×
- 1.59
- –
- –
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 24%of 989
Bottom 34%of 954
Bottom 43%of 933
Top 47%of 988
2.8%of the share price, paid each year
On $1,000 invested$28a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
: 110.3%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
20No pass
Benjamin Graham
54No pass
Philip Fisher
22No pass
Peter Lynch
30No pass
Joel Greenblatt
0No pass
Charlie Munger
22No pass
Terry Smith
16No pass
Questions about DSM-Firmenich
Is DSM-Firmenich a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the DSM-Firmenich AI analysis
What does DSM-Firmenich do?
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It is in Specialty Chemicals, based in Kaiseraugst, Switzerland, with 26,873 employees.
Does DSM-Firmenich pay a dividend?
Yes. At today's price the dividend is 2.8% a year. In 2025 it paid out €718 million in dividends.
Is DSM-Firmenich stock halal?
Yes. DSM-Firmenich passes our halal screen: its business is permitted and its debt is 21% of its market value, under the 30% limit. How we check
Who are DSM-Firmenich's competitors?
The largest listed companies in the same industry are Linde, L'Air Liquide, Ecolab and The Sherwin-Williams. The peers table on this page compares their profit, growth and price with DSM-Firmenich's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.